Author

Huiran Zheng

First Affiliated Hospital of Guangzhou Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2

Frequent Co-Authors

Banghui LiuiD· 2 shared Chuanying Niu· 2 shared Fandi WuiD· 2 shared Hang YuaniD· 2 shared Jianhua YaoiD· 2 shared Jincun ZhaoiD· 2 shared Qihong YaniD· 2 shared Xiaohan HuangiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Banghui LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintMar 23, 2026

Structural determinants of IGHV1-69 public antibodies conferring resilience to SARS-CoV-2 antigenic escape

Chuanying Niu, Xiaohan Huang, Qihong Yan…·Xiaoli Xiong

This study identifies structural features of affinity-matured R1-32-like antibodies that enable tolerance to SARS-CoV-2 mutations and reveals an ultrapotent antibody with broad variant activity.

DOI 10.64898/2025.12.19.695307

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 12, 2025

AI recognizes convergent somatic hypermutation signatures to allow the discovery of variant-resilient broadly neutralizing antibodies

Qihong Yan, Xiaohan Huang, Banghui Liu…·Jincun Zhao

The paper uses AI to identify convergent somatic hypermutation patterns in antibodies, enabling the discovery of variant-resilient broadly neutralizing antibodies from early-pandemic data.

3 citations

humanproteomics

𝕏 PostBluesky